VT-103

N/A

Report date: 2025/05/20 15:00:35
NME

Base Information

Drug NameVT-103
Drug Alias NameVT-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor TEF-1 inhibitors
TargetsTranscriptional enhancer factor TEF-1
Therapy Area/IndicationsAdenocarcinoma of Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyoto University
Inactive CompaniesN/A
Active IndicationsAdenocarcinoma of Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A